{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-001698","form_type":"8-K","ticker":"CELC","cik":"0001603454","company_name":"Celcuity Inc.","filed_at":"2025-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.159367+00:00","generated_at":"2026-05-24T01:51:52.964205+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.72,"calibrated_materiality_score":0.72,"confidence":"high","headline":"Celcuity posts Q4 net loss $36.7M, cash $235M, key trial data anticipated in 2025","bullets":["Q4 net loss $36.7M ($0.85/share) vs $18.8M ($0.65/share) in Q4 2023; full year net loss $111.8M ($2.83/share).","Cash, cash equivalents and short-term investments of $235.1M at Dec 31, 2024, expected to fund operations through 2026.","PIK3CA wild-type cohort of VIKTORIA-1 Phase 3 topline data expected Q2 2025; mutant cohort data in Q4 2025.","VIKTORIA-2 Phase 3 first patient enrollment on track for Q2 2025; Phase 1b/2 mCRPC data expected late Q2 2025.","R&D expenses increased to $33.5M in Q4 from $18.1M, driven by ongoing and new clinical trials."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-001698","json":"https://secwatch.observer/filing/0001641172-25-001698.json","markdown":"https://secwatch.observer/filing/0001641172-25-001698.md","text":"https://secwatch.observer/filing/0001641172-25-001698.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1603454/000164117225001698/0001641172-25-001698-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1603454/000164117225001698/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T01:51:52.964205+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}